Saba Capital Management, L.P. bought HQL
April 30, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 16,573 shares of Abrdn Life Sciences Investors at $13.13 per share, a transaction worth $217.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,573
Price
$13.13
Total value
$217.6K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 30, 2024
Filing dateMay 1, 2024
Shares owned after3,042,204
OwnershipIndirect
10b5-1 planNo
AmendedNo